Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lifeward Ltd LFWD

ReWalk Robotics Ltd. doing business as Lifeward is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive... see more

Recent & Breaking News (NDAQ:LFWD)

ReWalk Robotics to Present at Oppenheimer 17th Annual Israeli Conference on May 22nd in Tel Aviv

GlobeNewswire May 17, 2016

FirstService Declares Quarterly Cash Dividend on Common Shares

GlobeNewswire May 17, 2016

ReWalk Announces Collaboration with Harvard University's Wyss Institute to Develop Lightweight and Soft Exoskeleton Systems for the Treatment of Stroke, Multiple Sclerosis and Limited Mobility Patients

PR Newswire May 17, 2016

Commercial Health Insurance Company Becomes First to Implement Medical Policy Finding Powered Exoskeletons Medically Necessary

PR Newswire May 9, 2016

Department of Veterans Affairs Purchases 20 ReWalk Systems to Support National Multi-Center Trial Assessing Personal Exoskeleton System Use

PR Newswire May 5, 2016

ReWalk Robotics Reports First Quarter 2016 Financial Results

GlobeNewswire May 5, 2016

ReWalk Robotics to Discuss 2016 First Quarter Financial Results on May 5, 2016 Conference Call

GlobeNewswire April 25, 2016

First-Ever Meta-Analysis of Exoskeleton Technologies Concludes Powered Exoskeleton Systems Permit Safe Ambulation in Real-Life Settings and Produce Health Benefits

PR Newswire April 20, 2016

ReWalk Robotics Appoints Peter L. Wehrly to its Board of Directors

GlobeNewswire April 5, 2016

ReWalk Robotics to Present at Barclays Global Healthcare Conference

GlobeNewswire March 10, 2016

ReWalk Robotics Reports Fourth Quarter and Year-End 2015 Financial Results

GlobeNewswire February 25, 2016

German Social and Youth Agency Reimburses ReWalk Robotics Exoskeleton for the First Time

PR Newswire February 24, 2016

ReWalk Reports Co.'s Exoskeleton Has Been Deemed Medically Necessary by an Independent Medical Review Organization

Press Releases February 16, 2016

ReWalk Robotics Exoskeleton Deemed Medically Necessary by Independent Medical Review Organization

Press Releases February 16, 2016

ReWalk Robotics to Discuss 2015 Fourth Quarter and Full Year Financial Results on February 25, 2016 Conference Call

GlobeNewswire February 4, 2016

ReWalk Featured in Details of Department of Veterans Affairs' National Multi-Center Clinical Exoskeleton Trial

PR Newswire February 3, 2016

Peer-Reviewed Case Study Demonstrates Various Health Improvements Following ReWalk Exoskeleton Use

PR Newswire January 27, 2016

3 Key Takeaways from Bionik Labs' Biotech Showcase Presentation

Accesswire January 25, 2016

Attention for Bionik Labs Building with Investor Showcases for its Groundbreaking Aid for Ambulation

Accesswire January 12, 2016

Poised to Profit as Robotic Exoskeletons Go Mainstream

Accesswire January 5, 2016